Forward Citations = 102

Loading Chart...

1 inventor (with patents filed for the assignee):

Kary B Mullis (4 out of 7 patents)

4 patents: Sort by Forward Citations

1. 8591910 - Chemically programmable immunity (2013-11-26),

2. 8263082 - Chemically programmable immunity (2012-09-11),

3. 8236321 - Chemically programmable immunity (2012-08-07),

4. 7850975 - Chemically programmable immunity (2010-12-14),

Altermune Technologies LLC is a biotechnology company based in California, specializing in developing novel therapeutics to treat infectious diseases. Their innovative platform uses antibody mimetics to target pathogens and modulate the immune system, providing a new approach to fighting infections. With a team of experienced scientists and a commitment to advancing medical research, Altermune is dedicated to improving global health through cutting-edge technology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

4 Patents

#7 in Corona Del Mar, CA

#13,662 in California

#58,999 in US

Corona Del Mar, CA, United States of America

Altermune Technologies LLC

Forward Citations = 102

1 inventor:

Kary B Mullis (4 out of 7 patents)

Please report any incorrect information to support@idiyas.com